BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7969954)

  • 1. Distal lower motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide.
    Pestronk A; Lopate G; Kornberg AJ; Elliott JL; Blume G; Yee WC; Goodnough LT
    Neurology; 1994 Nov; 44(11):2027-31. PubMed ID: 7969954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lower motor neuron disease and signs of dysimmunity].
    Azulay JP; Attarian S; Boucraut J; Pouget J
    Rev Neurol (Paris); 2000 Apr; 156(4):372-9. PubMed ID: 10795014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy.
    Yuki N; Watanabe H; Nakajima T; Späth PJ
    J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):87-91. PubMed ID: 20667861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy.
    Nobile-Orazio E; Meucci N; Barbieri S; Carpo M; Scarlato G
    Neurology; 1993 Mar; 43(3 Pt 1):537-44. PubMed ID: 8450997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-MAG antibody-associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide.
    Blume G; Pestronk A; Goodnough LT
    Neurology; 1995 Aug; 45(8):1577-80. PubMed ID: 7543988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term follow up of multifocal motor neuropathy with conduction block under treatment.
    Azulay JP; Rihet P; Pouget J; Cador F; Blin O; Boucraut J; Serratrice G
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):391-4. PubMed ID: 9120457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive treatment in lower motor neuron syndrome with autoantibodies against GM1 ganglioside.
    Tsai CP; Lin KP; Liao KK; Wang SJ; Wang V; Kao KP; Wu ZA
    Eur Neurol; 1993; 33(6):446-9. PubMed ID: 8307067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder.
    Tan E; Lynn DJ; Amato AA; Kissel JT; Rammohan KW; Sahenk Z; Warmolts JR; Jackson CE; Barohn RJ; Mendell JR
    Arch Neurol; 1994 Feb; 51(2):194-200. PubMed ID: 8304845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor conduction block and high titres of anti-GM1 ganglioside antibodies: pathological evidence of a motor neuropathy in a patient with lower motor neuron syndrome.
    Adams D; Kuntzer T; Steck AJ; Lobrinus A; Janzer RC; Regli F
    J Neurol Neurosurg Psychiatry; 1993 Sep; 56(9):982-7. PubMed ID: 8410039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates.
    Pestronk A; Choksi R
    Neurology; 1997 Nov; 49(5):1289-92. PubMed ID: 9371910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal motor neuropathy: diagnosis and treatment.
    Pestronk A
    Neurology; 1998 Dec; 51(6 Suppl 5):S22-4. PubMed ID: 9851726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor neuropathies and serum IgM binding to NS6S heparin disaccharide or GM1 ganglioside.
    Pestronk A; Chuquilin M; Choksi R
    J Neurol Neurosurg Psychiatry; 2010 Jul; 81(7):726-30. PubMed ID: 20581137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical correlates of high-titer IgG anti-GM1 antibodies.
    Kornberg AJ; Pestronk A; Bieser K; Ho TW; McKhann GM; Wu HS; Jiang Z
    Ann Neurol; 1994 Feb; 35(2):234-7. PubMed ID: 8109905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].
    Léger JM; Viala K; Maisonobe T; Bouche P
    Bull Acad Natl Med; 2007 Oct; 191(7):1395-407; discussion 1407-9. PubMed ID: 18447061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IgM anti-GM1 ganglioside antibodies in lower motor neuron syndromes.
    Niebroj-Dobosz I; Janik P; Kwieciński H
    Eur J Neurol; 2004 Jan; 11(1):13-6. PubMed ID: 14692882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of distal lower motor neuron syndrome associated with IgM anti-GM1 antibodies].
    Hayashi Y; Yuki N; Yoshino H; Kaneko K; Miyatake T
    Rinsho Shinkeigaku; 1991 Jun; 31(6):674-6. PubMed ID: 1934786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study.
    Azulay JP; Blin O; Pouget J; Boucraut J; Billé-Turc F; Carles G; Serratrice G
    Neurology; 1994 Mar; 44(3 Pt 1):429-32. PubMed ID: 8145910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical and diagnostic role of anti-GM1 antibody testing.
    Kornberg AJ; Pestronk A
    Muscle Nerve; 1994 Jan; 17(1):100-4. PubMed ID: 8264687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies.
    Pestronk A
    Muscle Nerve; 1991 Oct; 14(10):927-36. PubMed ID: 1658646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and electrophysiologic correlates of elevated anti-GM1 antibody titers.
    Kinsella LJ; Lange DJ; Trojaborg W; Sadiq SA; Younger DS; Latov N
    Neurology; 1994 Jul; 44(7):1278-82. PubMed ID: 8035930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.